Prostatic Artery Embolization versus Standard Surgical Treatment for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Systematic Review and Meta-analysis

Berry, 1984, The development of human benign prostatic hyperplasia with age, J Urol, 132, 474, 10.1016/S0022-5347(17)49698-4

Gravas, 2018

McVary, 2010

Bruskewitz, 1998, A prospective, randomized 1-year clinical trial comparing transurethral needle ablation to transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia, J Urol, 159, 1588, 10.1097/00005392-199805000-00048

Hoffman, 2012, Microwave thermotherapy for benign prostatic hyperplasia, Cochrane Database Syst Rev, 10.1002/14651858.CD004135.pub3

Ahyai, 2010, Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement, Eur Urol, 58, 384, 10.1016/j.eururo.2010.06.005

Reich, 2008, Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10,654 patients, J Urol, 180, 246, 10.1016/j.juro.2008.03.058

DeMeritt, 2000, Relief of benign prostatic hyperplasia-related bladder outlet obstruction after transarterial polyvinyl alcohol prostate embolization, J Vasc Interv Radiol, 11, 767, 10.1016/S1051-0443(07)61638-8

Bilhim, 2015, Prostatic arterial embolization versus transurethral resection of the prostate for benign prostatic hyperplasia, Radiology, 276, 310, 10.1148/radiol.2015141853

Shim, 2017, Efficacy and safety of prostatic arterial embolization: systematic review with meta-analysis and meta-regression, J Urol, 197, 465, 10.1016/j.juro.2016.08.100

Vreugdenburg, 2018, Prostate artery embolisation: poor design and reporting impact the value of current systematic reviews, Eur Urol, 73, 642, 10.1016/j.eururo.2017.12.005

Knoll, 2018, Key steps in conducting systematic reviews for underpinning clinical practice guidelines: methodology of the European Association of Urology, Eur Urol, 73, 290, 10.1016/j.eururo.2017.08.016

Moher, 2009, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement, J Clin Epidemiol, 62, 1006, 10.1016/j.jclinepi.2009.06.005

Higgins, 2011, The Cochrane Collaboration's tool for assessing risk of bias in randomised trials, BMJ, 343, 10.1136/bmj.d5928

Sterne, 2016, ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions, BMJ, 355

Hozo, 2005, Estimating the mean and variance from the median, range, and the size of a sample, BMC Med Res Methodol, 5, 13, 10.1186/1471-2288-5-13

Guyatt, 2008, GRADE: an emerging consensus on rating quality of evidence and strength of recommendations, BMJ, 336, 924, 10.1136/bmj.39489.470347.AD

Carnevale, 2016, Transurethral resection of the prostate (TURP) versus original and PErFecTED prostate artery embolization (PAE) due to benign prostatic hyperplasia (BPH): Preliminary results of a single center, prospective, urodynamic-controlled analysis, Cardiovasc Intervent Radiol, 39, 44, 10.1007/s00270-015-1202-4

Gao, 2014, Benign prostatic hyperplasia: prostatic arterial embolization versus transurethral resection of the prostate–a prospective, randomized, and controlled clinical trial, Radiology, 270, 920, 10.1148/radiol.13122803

Abt, 2018, Comparison of prostatic artery embolisation (PAE) versus transurethral resection of the prostate (TURP) for benign prostatic hyperplasia: randomised, open label, non-inferiority trial, BMJ, 361

Ray, 2018, Efficacy and safety of prostate artery embolization for benign prostatic hyperplasia: an observational study and propensity-matched comparison with transurethral resection of the prostate (the UK-ROPE study), BJU Int, 122, 270, 10.1111/bju.14249

Russo, 2015, Prostatic arterial embolization vs open prostatectomy: a 1-year matched-pair analysis of functional outcomes and morbidities, Urology, 86, 343, 10.1016/j.urology.2015.04.037

Dindo, 2004, Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey, Ann Surg, 240, 205, 10.1097/01.sla.0000133083.54934.ae

Barry, 1995, Benign prostatic hyperplasia specific health status measures in clinical research: how much change in the American Urological Association symptom index and the benign prostatic hyperplasia impact index is perceptible to patients?, J Urol, 154, 1770, 10.1016/S0022-5347(01)66780-6

Schreuder, 2014, The role of prostatic arterial embolization in patients with benign prostatic hyperplasia: a systematic review, Cardiovasc Intervent Radiol, 37, 1198, 10.1007/s00270-014-0948-4

Nair, 2015, Evolving and investigational therapies for benign prostatic hyperplasia, Can J Urol, 22, 82

McWilliams, 2014, Society of Interventional Radiology position statement: prostate artery embolization for treatment of benign disease of the prostate, J Vasc Interv Radiol, 25, 1349, 10.1016/j.jvir.2014.05.005

Golzarian, 2014, Prostatic artery embolization to treat lower urinary tract symptoms related to benign prostatic hyperplasia and bleeding in patients with prostate cancer: proceedings from a multidisciplinary research consensus panel, J Vasc Interv Radiol, 25, 665, 10.1016/j.jvir.2013.11.003

Kuntz, 2008, Holmium laser enucleation of the prostate versus open prostatectomy for prostates greater than 100 grams: 5-year follow-up results of a randomised clinical trial, Eur Urol, 53, 160, 10.1016/j.eururo.2007.08.036

Swiss Federal Office of Public Health, 2018

Andrade, 2017, Radiation exposure of patients and interventional radiologists during prostatic artery embolization: a prospective single-operator study, J Vasc Interv Radiol, 28, 517, 10.1016/j.jvir.2017.01.005

Maclean, 2018, Factors predicting a good symptomatic outcome after prostate artery embolisation (PAE), Cardiovasc Intervent Radiol, 1

Bilhim, 2016, Predictors of clinical outcome after prostate artery embolization with spherical and nonspherical polyvinyl alcohol particles in patients with benign prostatic hyperplasia, Radiology, 281, 289, 10.1148/radiol.2016152292

Wang, 2016, Prostatic arterial embolization for the treatment of lower urinary tract symptoms caused by benign prostatic hyperplasia: a comparative study of medium- and large-volume prostates, BJU Int, 117, 155, 10.1111/bju.13147